Cediranib
Cediranib
Cediranib (pronunciation: se-DIR-a-nib) is a potent and highly selective inhibitor of vascular endothelial growth factor (VEGF) receptor tyrosine kinases. It is used in the treatment of various types of cancer, including ovarian cancer, lung cancer, and glioblastoma.
Etymology
The name "Cediranib" is derived from the chemical name CED Indazolylmethyl Receptor Antagonist Nitro Imidazole Benzimidazole.
Usage
Cediranib is used in the treatment of various types of cancer. It works by inhibiting the growth of new blood vessels (a process known as angiogenesis) that tumors need to grow. By blocking angiogenesis, cediranib can slow the growth of tumors and in some cases, shrink them.
Related Terms
- Angiogenesis: The formation of new blood vessels. This process is critical for the growth of cancerous tumors.
- Inhibitor: A substance that slows down or prevents a particular chemical reaction or other processes.
- Ovarian Cancer: A type of cancer that begins in the ovaries.
- Lung Cancer: A type of cancer that begins in the lungs.
- Glioblastoma: A type of brain cancer. It's the most aggressive cancer that begins within the brain.
Side Effects
Like all medications, cediranib can cause side effects. Common side effects include fatigue, diarrhea, nausea, high blood pressure, and loss of appetite. Less common but more serious side effects can include bleeding, wound healing complications, and heart failure.
External links
- Medical encyclopedia article on Cediranib
- Wikipedia's article - Cediranib
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski